ID
37354
Description
Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This form contains details on the administration of the investigational product and is to be filled in at Day 1, 2 and 3. Additionally, this form also contains Randomisation information and the assignment of the participant to one of the four cohorts for/prior to the first medication administration.
Link
https://clinicaltrials.gov/ct2/show/NCT00996840
Keywords
Versions (2)
- 7/16/19 7/16/19 -
- 7/20/19 7/20/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
July 20, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
SB-681323 in ALI/ARDS risk patients - NCT00996840
Investigational Product - IV Dosing, Randomisation, Cohort Assignment
Description
First Administration
Alias
- UMLS CUI-1
- C3469597 (Administration of medication)
- SNOMED
- 18629005
Description
Cohorts 1/3: 0-4 hrs Cohorts 2/4: 0-24hrs
Data type
integer
Alias
- UMLS CUI [1,1]
- C0449238 (Duration (temporal concept))
- SNOMED
- 762636008
- LOINC
- LP14744-4
- UMLS CUI [1,2]
- C3469597 (Administration of medication)
- SNOMED
- 18629005
- UMLS CUI [1,3]
- C0304229 (Experimental drug)
Description
Start Date and Time
Data type
datetime
Alias
- UMLS CUI [1]
- C3897500 (Start Date and Time of Procedure)
Description
Stop Date and Time
Data type
datetime
Alias
- UMLS CUI [1]
- C3899266 (End Date and Time of Procedure)
Description
Volume administered
Data type
float
Measurement units
- mL
Alias
- UMLS CUI [1]
- C2349139 (Volume Administered)
Description
Administration post interruption
Alias
- UMLS CUI-1
- C3469597 (Administration of medication)
- SNOMED
- 18629005
- UMLS CUI-2
- C0687676 (Post)
- SNOMED
- 288563008
- LOINC
- LP20512-7
- UMLS CUI-3
- C1512900 (Interruption)
Description
Cohorts 1/3: 0-4 hrs Cohorts 2/4: 0-24 hrs
Data type
integer
Alias
- UMLS CUI [1,1]
- C0449238 (Duration (temporal concept))
- SNOMED
- 762636008
- LOINC
- LP14744-4
- UMLS CUI [1,2]
- C3469597 (Administration of medication)
- SNOMED
- 18629005
- UMLS CUI [1,3]
- C0304229 (Experimental drug)
Description
Start Date and Time
Data type
datetime
Alias
- UMLS CUI [1]
- C3897500 (Start Date and Time of Procedure)
Description
Stop Date and Time
Data type
datetime
Alias
- UMLS CUI [1]
- C3899266 (End Date and Time of Procedure)
Description
Volume administered
Data type
float
Measurement units
- mL
Alias
- UMLS CUI [1]
- C2349139 (Volume Administered)
Description
Investigational Product Container Number
Alias
- UMLS CUI-1
- C0304229 (Experimental drug)
- UMLS CUI-2
- C0180098 (Containers)
- SNOMED
- 706437002
- UMLS CUI-3
- C0600091 (Identifier)
- SNOMED
- 118522005
- LOINC
- LP31795-5
Description
Record the identifying number from the investigational product container dispensed at this visit
Data type
text
Alias
- UMLS CUI [1,1]
- C0304229 (Experimental drug)
- UMLS CUI [1,2]
- C0180098 (Containers)
- SNOMED
- 706437002
- UMLS CUI [1,3]
- C0600091 (Identifier)
- SNOMED
- 118522005
- LOINC
- LP31795-5
Description
Treatment Confirmation
Alias
- UMLS CUI-1
- C0750484 (Confirmation)
- LOINC
- LA15290-2
- UMLS CUI-2
- C0087111 (Therapeutic procedure)
- SNOMED
- 277132007
- LOINC
- LP21090-3
Description
If no, record reasons
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0087111 (Therapeutic procedure)
- SNOMED
- 277132007
- LOINC
- LP21090-3
- UMLS CUI [1,2]
- C2349182 (Correct (qualifier))
- LOINC
- LA9960-1
Description
if applicable
Data type
text
Alias
- UMLS CUI [1,1]
- C0566251 (Reason and justification)
- SNOMED
- 288830005
- UMLS CUI [1,2]
- C0087111 (Therapeutic procedure)
- SNOMED
- 277132007
- LOINC
- LP21090-3
- UMLS CUI [1,3]
- C3827420 (Wrong)
- LOINC
- LA7342-4
Description
Randomisation Number
Alias
- UMLS CUI-1
- C0034656 (Randomization)
- UMLS CUI-2
- C0237753 (Numbers)
- SNOMED
- 260299005
- LOINC
- LP6841-3
Description
If yes, provide Randomisation Number and Date/time of randomisation
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0034656 (Randomization)
- UMLS CUI [1,2]
- C0332149 (Possible)
- SNOMED
- 371930009
- LOINC
- LA15097-1
Description
if applicable
Data type
integer
Alias
- UMLS CUI [1,1]
- C0034656 (Randomization)
- UMLS CUI [1,2]
- C0237753 (Numbers)
- SNOMED
- 260299005
- LOINC
- LP6841-3
Description
if applicable
Data type
datetime
Alias
- UMLS CUI [1,1]
- C0034656 (Randomization)
- UMLS CUI [1,2]
- C1264639 (Date/Time)
- SNOMED
- 118575009
Similar models
Investigational Product - IV Dosing, Randomisation, Cohort Assignment
C1516050 (UMLS CUI [1,2])
C1264639 (UMLS CUI [1,3])
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0687676 (UMLS CUI-2)
C1512900 (UMLS CUI-3)
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0180098 (UMLS CUI-2)
C0600091 (UMLS CUI-3)
C0180098 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
C0087111 (UMLS CUI-2)
C2349182 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C3827420 (UMLS CUI [1,3])
C0332149 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C1264639 (UMLS CUI [1,2])
No comments